Related Experiment Video
Updated: Dec 28, 2025

In Vitro Analysis of E3 Ubiquitin Ligase Function
Published on: May 14, 2021
CRL4Cdt2: Coupling Genome Stability to Ubiquitination
Andreas Panagopoulos1, Stavros Taraviras2, Hideo Nishitani3
1Department of General Biology, School of Medicine, University of Patras, Patras 26504, Greece.
Abstract:
The cullin-RING E3 ubiquitin ligase CRL4Cdt2 has emerged as a master regulator of genome stability, which targets key cell cycle proteins for proteolysis during S phase and after DNA damage. Recent advances shed light on how it couples ubiquitination to DNA synthesis, offering a new paradigm for substrate recognition: Cdt2 binds directly onto proliferating cell nuclear antigen (PCNA) loaded on DNA, which serves as a landing pad for the independent recruitment of the ubiquitin ligase and its substrates. Cyclin-dependent kinases (CDKs) and the ataxia telangiectasia and Rad3-related (ATR) kinase ensure accurate spatiotemporal regulation of CRL4Cdt2 under normal conditions and upon DNA damage. Deregulation of Cdt2 is evident in malignancies and was recently highlighted as a major target of oncogenic viruses, supporting the therapeutic targeting of the ligase as a promising anticancer strategy.
Insights
The CRL4Cdt2 E3 ubiquitin ligase regulates genome stability by targeting cell cycle proteins. It binds DNA-loaded PCNA, offering a new model for substrate recognition and potential cancer therapeutic strategies.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- The cullin-RING E3 ubiquitin ligase CRL4Cdt2 is crucial for maintaining genome stability.
- It targets key cell cycle proteins for degradation during S phase and in response to DNA damage.
Purpose of the Study:
- To elucidate the mechanism of CRL4Cdt2 substrate recognition.
- To explore the role of CRL4Cdt2 in genome integrity and its therapeutic potential.
Main Methods:
- Investigated CRL4Cdt2 interactions with PCNA and substrates.
- Examined the role of CDKs and ATR in regulating CRL4Cdt2 activity.
Main Results:
- CRL4Cdt2 utilizes proliferating cell nuclear antigen (PCNA) on DNA as a platform for substrate recruitment.
- This mechanism couples ubiquitination to DNA synthesis and ensures proper cell cycle progression.
- CDKs and ATR kinases provide spatiotemporal control over CRL4Cdt2 function.
Conclusions:
- CRL4Cdt2-PCNA interaction represents a novel paradigm for E3 ligase substrate targeting.
- Dysregulation of CRL4Cdt2 is linked to cancer and viral infections.
- Targeting CRL4Cdt2 is a promising anticancer therapeutic strategy.
Related Concept Videos
Anaphase Promoting Complex
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle

